Australian-first detector to accelerate cancer research
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
Showing 361 - 380 of 535 results
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
Radiation testing of electronic components at ANTO could benefit the aviation industry, regulators and most importantly, passengers as solar radiation events increase.
Development of new techniques makes it possible to date Australian Aboriginal rock art.
The National Deuteration Facility has supplied deuterium labelled lipids to quantify lipid biomarkers in a blood test to help diagnose breast cancer.
A large group of ANSTO environmental scientists and collaborators have produced the first groundwater stable isotopes, ‘isoscapes’, intuitive maps with grid data, across NSW combining new and pre-existing isotope measurements.
Padstow North and Caringbah North selected as winners of ANSTO's Top Coder competition.
Clarity Pharmaceuticals is building on comprehensive work on chelators carried out at ANSTO.
Research on the mechanism of cell death has insights to bring progress on neurodegenerative diseases and plant biosecurity.
Research to understand how contaminants move through the soil and affect ecosystems and humans as well estimating emissions.
Monica Hibberd and Hamish McDougall are working together on research into greener and more efficient energy and battery technology.
Modifications to promising novel non-fullerene small molecule acceptor in organic thin film for solar cells demonstrates improved power conversion efficiency.
Nine PhD students are taking part in a rare opportunity to deliver an innovative solution to a real-world challenge for an industry partner in ANSTO’s National Graduate Innovation Forum in association with the Australian Council of Deans of Science and the Australian Institute of Nuclear Science and Engineering.
Australia’s nuclear agency ANSTO is continuing to lead planning efforts to repatriate what is called a TN-81 cask of intermediate-level radioactive from the United Kingdom in 2022.